{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:14:46Z","timestamp":1792692886876,"version":"4.5.0"},"reference-count":106,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009002","name":"Ministry of Education and Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,27]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cryptococcosis causes a high burden of disease worldwide. This systematic review summarizes the literature on Cryptococcus neoformans and C. gattii infections to inform the World Health Organization\u2019s first Fungal Priority Pathogen List. PubMed and Web of Science were used to identify studies reporting on annual incidence, mortality, morbidity, antifungal resistance, preventability, and distribution\/emergence in the past 10\u2009years. Mortality rates due to C. neoformans were 41%\u201361%. Complications included acute renal impairment, raised intracranial pressure needing shunts, and blindness. There was moderate evidence of reduced susceptibility (MIC range 16\u201332\u2009mg\/l) of C. neoformans to fluconazole, itraconazole, ketoconazole, voriconazole, and amphotericin B. Cryptococcus gattii infections comprised 11%\u201333% of all cases of invasive cryptococcosis globally. The mortality rates were 10%\u201323% for central nervous system (CNS) and pulmonary infections, and \u223c43% for bloodstream infections. Complications described included neurological sequelae (17%\u201327% in C. gattii infections) and immune reconstitution inflammatory syndrome. MICs were generally low for amphotericin B (MICs: 0.25\u20130.5\u2009mg\/l), 5-flucytosine (MIC range: 0.5\u20132\u2009mg\/l), itraconazole, posaconazole, and voriconazole (MIC range: 0.06\u20130.5\u2009mg\/l). There is a need for increased surveillance of disease phenotype and outcome, long-term disability, and drug susceptibility to inform robust estimates of disease burden.<\/jats:p>","DOI":"10.1093\/mmy\/myae043","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T20:12:22Z","timestamp":1719519142000},"source":"Crossref","is-referenced-by-count":52,"title":["Cryptococcosis\u2014a systematic review to inform the World Health Organization Fungal Priority Pathogens List"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0631-2975","authenticated-orcid":false,"given":"Aiken","family":"Dao","sequence":"first","affiliation":[{"name":"Sydney Infectious Diseases Institute, The University of Sydney , Sydney , Australia"},{"name":"Westmead Institute for Medical Research , Westmead, Sydney , Australia"},{"name":"Westmead Clinical School, Westmead Hospital , Sydney , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah Yejin","family":"Kim","sequence":"additional","affiliation":[{"name":"Sydney Infectious Diseases Institute, The University of Sydney , Sydney , Australia"},{"name":"Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney , Camperdown , Australia"},{"name":"Department of Pharmacy, Westmead Hospital , Westmead , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Garnham","sequence":"additional","affiliation":[{"name":"Sydney Infectious Diseases Institute, The University of Sydney , Sydney , Australia"},{"name":"Sunshine Coast University Hospital , Birtinya, Qld 4575 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5957-4178","authenticated-orcid":false,"given":"Sarah","family":"Kidd","sequence":"additional","affiliation":[{"name":"National Mycology Reference Centre, Microbiology and Infectious Diseases, SA Pathology , Adelaide , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatim","family":"Sati","sequence":"additional","affiliation":[{"name":"AMR Division, World Health Organization , Geneva , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Perfect","sequence":"additional","affiliation":[{"name":"Duke University Medical Center , Durham, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9460-0960","authenticated-orcid":false,"given":"Tania C","family":"Sorrell","sequence":"additional","affiliation":[{"name":"Sydney Infectious Diseases Institute, The University of Sydney , Sydney , Australia"},{"name":"Westmead Institute for Medical Research , Westmead, Sydney , Australia"},{"name":"Westmead Clinical School, Westmead Hospital , Sydney , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Harrison","sequence":"additional","affiliation":[{"name":"Institute of Infection and Immunity, St George\u2019s University London , London , UK"},{"name":"Medical Research Council Centre for Medical Mycology, University of Exeter , Exeter , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Rickerts","sequence":"additional","affiliation":[{"name":"Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Gigante","sequence":"additional","affiliation":[{"name":"AMR Division, World Health Organization , Geneva , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8651-4405","authenticated-orcid":false,"given":"Ana","family":"Alastruey-Izquierdo","sequence":"additional","affiliation":[{"name":"Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III , Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6703-0288","authenticated-orcid":false,"given":"Jan-Willem","family":"Alffenaar","sequence":"additional","affiliation":[{"name":"Sydney Infectious Diseases Institute, The University of Sydney , Sydney , Australia"},{"name":"Westmead Clinical School, Westmead Hospital , Sydney , Australia"},{"name":"Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney , Camperdown , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Orla","family":"Morrissey","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Alfred Health , Melbourne , Australia"},{"name":"Monash University, Department of Infectious Diseases , Melbourne, Victoria , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9983-6603","authenticated-orcid":false,"given":"Sharon C-A","family":"Chen","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, New South Wales Health Pathology, Westmead Hospital , Westmead, Sydney , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1978-1559","authenticated-orcid":false,"given":"Justin","family":"Beardsley","sequence":"additional","affiliation":[{"name":"Sydney Infectious Diseases Institute, The University of Sydney , Sydney , Australia"},{"name":"Westmead Institute for Medical Research , Westmead, Sydney , Australia"},{"name":"Westmead Clinical School, Westmead Hospital , Sydney , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,27]]},"reference":[{"issue":"4","key":"2024062717013902000_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/jof3040057","article-title":"Global and multi-national prevalence of fungal diseases-estimate precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J Fungi (Basel)"},{"key":"2024062717013902000_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.fgb.2015.02.009","article-title":"Recognition of seven species in the Cryptococcus gattii\/Cryptococcus neoformans species complex","volume":"78","author":"Hagen","year":"2015","journal-title":"Fungal Genet Biol"},{"issue":"4","key":"2024062717013902000_bib3","doi-asserted-by":"crossref","first-page":"e1000850","DOI":"10.1371\/journal.ppat.1000850","article-title":"Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the Northwest United States","volume":"6","author":"Byrnes","year":"2010","journal-title":"PLoS Pathog"},{"issue":"2","key":"2024062717013902000_bib4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/313992","article-title":"Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group","volume":"31","author":"Chen","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"49","key":"2024062717013902000_bib5","doi-asserted-by":"crossref","first-page":"17258","DOI":"10.1073\/pnas.0402981101","article-title":"A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada)","volume":"101","author":"Kidd","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2024062717013902000_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/microorganisms10010013","article-title":"Recent advances in cryptococcus and cryptococcosis","volume":"10","author":"Firacative","year":"2021","journal-title":"Microorganisms"},{"issue":"1","key":"2024062717013902000_bib7","doi-asserted-by":"crossref","first-page":"e0005223","DOI":"10.1371\/journal.pntd.0005223","article-title":"MLST-based population genetic analysis in a global context reveals clonality amongst Cryptococcus neoformans var. grubii VNI isolates from HIV patients in southeastern Brazil","volume":"11","author":"Ferreira-Paim","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"2024062717013902000_bib8","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/QCO.0000000000000458","article-title":"Treatment of cryptococcosis in non-HIV immunocompromised patients","volume":"31","author":"Henao-Mart\u00ednez","year":"2018","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"2024062717013902000_bib9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.idc.2006.07.001","article-title":"Cryptococcosis","volume":"20","author":"Chayakulkeeree","year":"2006","journal-title":"Infect Dis Clin North Am"},{"key":"2024062717013902000_bib10","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.3389\/fmicb.2019.02903","article-title":"A new age in molecular diagnostics for invasive fungal disease: are we ready?","volume":"10","author":"Kidd","year":"2019","journal-title":"Front Microbiol"},{"issue":"1","key":"2024062717013902000_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10156-011-0306-2","article-title":"Paradoxical roles of alveolar macrophages in the host response to Cryptococcus neoformans","volume":"18","author":"McQuiston","year":"2012","journal-title":"J Infect Chemother"},{"issue":"9","key":"2024062717013902000_bib12","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1128\/IAI.00454-09","article-title":"Role of dendritic cells and alveolar macrophages in regulating early host defense against pulmonary infection with Cryptococcus neoformans","volume":"77","author":"Osterholzer","year":"2009","journal-title":"Infect Immun"},{"issue":"16","key":"2024062717013902000_bib13","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1097\/QAD.0b013e3282a4a64d","article-title":"HIV-associated cryptococcal meningitis","volume":"21","author":"Jarvis","year":"2007","journal-title":"AIDS"},{"issue":"10","key":"2024062717013902000_bib14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1258\/ijsa.2010.010182","article-title":"An update on Cryptococcus among HIV-infected patients","volume":"21","author":"Warkentien","year":"2010","journal-title":"Int J STD AIDS"},{"issue":"12","key":"2024062717013902000_bib15","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/S1473-3099(22)00499-6","article-title":"The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis","volume":"22","author":"Rajasingham","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"2024062717013902000_bib16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrmicro.2015.6","article-title":"Cryptococcus: from environmental saprophyte to global pathogen","volume":"14","author":"May","year":"2016","journal-title":"Nat Rev Micro"},{"issue":"7","key":"2024062717013902000_bib17","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1172\/JCI136223","article-title":"Dormancy in Cryptococcus neoformans: 60 years of accumulating evidence","volume":"130","author":"Alanio","year":"2020","journal-title":"J Clin Invest"},{"issue":"2","key":"2024062717013902000_bib18","doi-asserted-by":"crossref","first-page":"e02580","DOI":"10.1128\/mBio.02580-14","article-title":"Cryptococcus neoformans host adaptation: toward biological evidence of dormancy","volume":"6","author":"Alanio","year":"2015","journal-title":"mBio"},{"issue":"6","key":"2024062717013902000_bib19","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/EC.00039-10","article-title":"Cryptococcal interactions with the host immune system","volume":"9","author":"Voelz","year":"2010","journal-title":"Euk Cell"},{"issue":"4","key":"2024062717013902000_bib20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1567-1364.2006.00051.x","article-title":"Cryptococcus neoformans: the yeast that likes it hot","volume":"6","author":"Perfect","year":"2006","journal-title":"FEMS Yeast Res"},{"issue":"4","key":"2024062717013902000_bib21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/jof3040064","article-title":"Adaptive immunity to Cryptococcus neoformans infections","volume":"3","author":"Mukaremera","year":"2017","journal-title":"J Fungi (Basel)"},{"issue":"8","key":"2024062717013902000_bib22","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"2024062717013902000_bib23","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s11739-020-02619-2","article-title":"Cryptococcal meningitis: a review for emergency clinicians","volume":"16","author":"Fisher","year":"2021","journal-title":"Intern Emerg Med"},{"key":"2024062717013902000_bib24","doi-asserted-by":"crossref","first-page":"642658","DOI":"10.3389\/fcimb.2021.642658","article-title":"Comparison of Cryptococcus gattii\/neoformans species complex to related genera (Papiliotrema and Naganishia) reveal variances in virulence associated factors and antifungal susceptibility","volume":"11","author":"Oliveira","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"2024062717013902000_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/myc.12444","article-title":"Comparison of biotyping methods as alternative identification tools to molecular typing of pathogenic Cryptococcus species in sub-Saharan Africa","volume":"59","author":"Nyazika","year":"2016","journal-title":"Mycoses"},{"issue":"6","key":"2024062717013902000_bib26","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMoa1509024","article-title":"Adjunctive dexamethasone in HIV-associated cryptococcal meningitis","volume":"374","author":"Beardsley","year":"2016","journal-title":"N Engl J Med"},{"issue":"7","key":"2024062717013902000_bib27","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41579-021-00511-0","article-title":"Treatment strategies for cryptococcal infection: challenges, advances and future outlook","volume":"19","author":"Iyer","year":"2021","journal-title":"Nat Rev Micro"},{"key":"2024062717013902000_bib28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/imj.15590","article-title":"Consensus guidelines for the diagnosis and management of cryptococcosis and rare yeast infections in the haematology\/oncology setting, 2021","volume":"51","author":"Chang","year":"2021","journal-title":"Intern Med J"},{"issue":"4","key":"2024062717013902000_bib29","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/S1473-3099(18)30493-6","article-title":"Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries","volume":"19","author":"Loyse","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2024062717013902000_bib30","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2024062717013902000_bib31","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"44","key":"2024062717013902000_bib32","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jclinepi.2012.09.016","article-title":"Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity","volume":"66","author":"Kim","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"2024062717013902000_bib45","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3109\/13693786.2012.761737","article-title":"Susceptibility profile of clinical and environmental isolates of Cryptococcus neoformans and Cryptococcus gattii in Uberaba, Minas Gerais, Brazil","volume":"51","author":"Andrade-Silva","year":"2013","journal-title":"Med Mycol"},{"issue":"3","key":"2024062717013902000_bib93","doi-asserted-by":"crossref","first-page":"e0193237","DOI":"10.1371\/journal.pone.0193237","article-title":"Genotypic analysis of clinical and environmental Cryptococcus neoformans isolates from Brazil reveals the presence of VNB isolates and a correlation with biological factors","volume":"13","author":"Andrade-Silva","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"2024062717013902000_bib94","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1038\/s41467-019-10092-5","article-title":"Three phylogenetic groups have driven the recent population expansion of Cryptococcus neoformans","volume":"10","author":"Ashton","year":"2019","journal-title":"Nat Commun"},{"issue":"12","key":"2024062717013902000_bib95","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/myc.13174","article-title":"Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans\/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil","volume":"63","author":"Bariao","year":"2020","journal-title":"Mycoses"},{"issue":"6","key":"2024062717013902000_bib33","doi-asserted-by":"crossref","first-page":"e0003847","DOI":"10.1371\/journal.pntd.0003847","article-title":"Genotypic Diversity Is Associated with Clinical Outcome and Phenotype in Cryptococcal Meningitis across Southern Africa","volume":"9","author":"Beale","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"2024062717013902000_bib58","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/1469-0691.12019","article-title":"Genotyping and antifungal susceptibility testing of Cryptococcus neoformans isolates from Cameroonian HIV-positive adult patients","volume":"19","author":"Bertout","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"2024062717013902000_bib71","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11046-018-0263-8","article-title":"Comparison of clinical features and prognostic factors of cryptococcal meningitis caused by Cryptococcus neoformans in patients with and without pulmonary nodules","volume":"184","author":"Cao","year":"2019","journal-title":"Mycopathologia"},{"key":"2024062717013902000_bib38","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijid.2014.05.019","article-title":"Clinical and microbiological characteristics of cryptococcosis in Singapore: predominance of Cryptococcus neoformans compared with Cryptococcus gattii","volume":"26","author":"Chan","year":"2014","journal-title":"Int J Infect Dis"},{"key":"2024062717013902000_bib47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12879-015-1023-8","article-title":"Increasing trend of fluconazole-non-susceptible Cryptococcus neoformans in patients with invasive cryptococcosis: a 12-year longitudinal study","volume":"15","author":"Chen","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2024062717013902000_bib46","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/s41598-018-20054-4","article-title":"Multilocus sequence typing reveals both shared and unique genotypes of Cryptococcus neoformans in Jiangxi Province, China","volume":"8","author":"Chen","year":"2018","journal-title":"Sci Rep"},{"issue":"Pt 7","key":"2024062717013902000_bib96","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1099\/jmm.0.029025-0","article-title":"In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India","volume":"60","author":"Chowdhary","year":"2011","journal-title":"J Med Microbiol"},{"issue":"8","key":"2024062717013902000_bib97","first-page":"963","article-title":"Epidemiological trends of cryptococcosis in Italy: molecular typing and susceptibility pattern of Cryptococcus neoformans isolates collected during a 20-year period","volume":"56","author":"Cogliati","year":"2018","journal-title":"Med Mycol"},{"issue":"6","key":"2024062717013902000_bib51","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/myc.12479","article-title":"Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina","volume":"59","author":"C\u00f3rdoba","year":"2016","journal-title":"Mycoses"},{"key":"2024062717013902000_bib98","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12281-017-0296-3","article-title":"Time-kill curves studies with amphotericin B against Cryptococcus neoformans\/C. gattii species complex clinical isolates","volume":"11","author":"de\u00a0Oliveira","year":"2017","journal-title":"Curr Fungal Infect Rep"},{"issue":"3","key":"2024062717013902000_bib99","doi-asserted-by":"crossref","first-page":"e00311","DOI":"10.1128\/mBio.00311-15","article-title":"Cryptococcosis serotypes impact outcome and provide evidence of Cryptococcus neoformans speciation","volume":"6","author":"Desnos-Ollivier","year":"2015","journal-title":"mBio"},{"issue":"11","key":"2024062717013902000_bib56","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1128\/AAC.01115-12","article-title":"Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, Itraconazole, posaconazole, and voriconazole","volume":"56","author":"Espinel-Ingroff","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"2024062717013902000_bib60","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1128\/AAC.06252-11","article-title":"Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine","volume":"56","author":"Espinel-Ingroff","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2024062717013902000_bib61","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1128\/AAC.04055-14","article-title":"Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for the Cryptococcus neoformans-Cryptococcus gattii species complex using the CLSI M27-A3 broth microdilution method","volume":"59","author":"Espinel-Ingroff","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"2024062717013902000_bib57","doi-asserted-by":"crossref","first-page":"887.e1","DOI":"10.1016\/j.cmi.2016.07.008","article-title":"Predominance of Cryptococcus neoformans var. grubii multilocus sequence type 5 and emergence of isolates with non-wild-type minimum inhibitory concentrations to fluconazole: a multi-centre study in China","volume":"22","author":"Fan","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"2024062717013902000_bib100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12223-015-0409-8","article-title":"Molecular typing of clinical isolates of Cryptococcus neoformans\/Cryptococcus gattii species complex from Northeast Mexico","volume":"61","author":"Gonzalez","year":"2016","journal-title":"Folia Microbiol (Praha)"},{"issue":"6","key":"2024062717013902000_bib101","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1128\/AAC.00048-11","article-title":"Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates obtained through population-based surveillance in South Africa in 2002-2003 and 2007-2008","volume":"55","author":"Govender","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"2024062717013902000_bib50","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1590\/S1517-838246420140564","article-title":"Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India","volume":"46","author":"Gutch","year":"2015","journal-title":"Braz J Microbiol"},{"issue":"9","key":"2024062717013902000_bib52","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/myc.12507","article-title":"Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark","volume":"59","author":"Hagen","year":"2016","journal-title":"Mycoses"},{"issue":"4","key":"2024062717013902000_bib53","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1099\/jmm.0.000698","article-title":"Molecular characterization and antifungal susceptibility testing of Cryptococcus neoformans sensu stricto from southern Brazil","volume":"67","author":"Herkert","year":"2018","journal-title":"J Med Microbiol"},{"issue":"1","key":"2024062717013902000_bib70","doi-asserted-by":"crossref","first-page":"97493","DOI":"10.1038\/s41598-019-43941-w","article-title":"Mortality due to Cryptococcus neoformans and Cryptococcus gattii in low-income settings: an autopsy study","volume":"9","author":"Hurtado","year":"2019","journal-title":"Sci Rep"},{"issue":"12","key":"2024062717013902000_bib66","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/myc.12539","article-title":"Molecular epidemiology reveals genetic diversity among 363 isolates of the Cryptococcus neoformans and Cryptococcus gattii species complex in 61 Ivorian HIV-positive patients","volume":"59","author":"Kassi","year":"2016","journal-title":"Mycoses"},{"issue":"5","key":"2024062717013902000_bib68","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/mmy\/myz097","article-title":"Clinical insights and epidemiology of central nervous system infection due to Cryptococcus neoformans\/gattii species complexes: a prospective study from South India","volume":"58","author":"Lahiri","year":"2020","journal-title":"Med Mycol"},{"issue":"3","key":"2024062717013902000_bib74","doi-asserted-by":"crossref","first-page":"e0119090","DOI":"10.1371\/journal.pone.0119090","article-title":"Risk factors for invasive Cryptococcus neoformans diseases: a case-control study","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"2024062717013902000_bib102","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.diagmicrobio.2014.09.006","article-title":"Comparison of Etests and Vitek 2 \u00ae to broth microdilution for the susceptibility testing of Cryptococcus neoformans","volume":"80","author":"Mahabeer","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"2024062717013902000_bib103","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.diagmicrobio.2014.09.006","article-title":"Comparison of Etests and Vitek 2 (R) to broth microdilution for the susceptibility testing of Cryptococcus neoformans","volume":"80","author":"Mahabeer","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"2024062717013902000_bib34","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1590\/S0074-02762011000600012","article-title":"Genotypes of Cryptococcus neoformans and Cryptococcus gattii as agents of endemic cryptococcosis in Teresina, Piaui (northeastern Brazil)","volume":"106","author":"Martins","year":"2011","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"5","key":"2024062717013902000_bib35","doi-asserted-by":"crossref","first-page":"E438","DOI":"10.1111\/j.1439-0507.2010.01946.x","article-title":"Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates from AIDS patients in Kenya","volume":"54","author":"Mdodo","year":"2011","journal-title":"Mycoses"},{"issue":"1","key":"2024062717013902000_bib67","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1128\/JCM.01277-10","article-title":"Analyses of pediatric isolates of Cryptococcus neoformans from South Africa","volume":"49","author":"Miglia","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"3","key":"2024062717013902000_bib104","doi-asserted-by":"crossref","first-page":"e0008137","DOI":"10.1371\/journal.pntd.0008137","article-title":"Decreasing fluconazole susceptibility of clinical South African Cryptococcus neoformans isolates over a decade","volume":"14","author":"Naicker","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"2024062717013902000_bib105","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1590\/s1678-9946201759049","article-title":"Cryptococcus neoformans and C. gattii isolates from both HIV-infected and uninfected patients: antifungal susceptibility and outcome of cryptococcal disease","volume":"59","author":"Nascimento","year":"2017","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"7","key":"2024062717013902000_bib106","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/mmy\/myy150","article-title":"Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods","volume":"57","author":"Nishikawa","year":"2019","journal-title":"Med Mycol"},{"issue":"11","key":"2024062717013902000_bib36","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1099\/jmm.0.000354","article-title":"Cryptococcus neoformans population diversity and clinical outcomes of HIV-associated cryptococcal meningitis patients in Zimbabwe","volume":"65","author":"Nyazika","year":"2016","journal-title":"J Med Microbiol"},{"issue":"3","key":"2024062717013902000_bib54","doi-asserted-by":"crossref","first-page":"e32868","DOI":"10.1371\/journal.pone.0032868","article-title":"Resistance of Asian Cryptococcus neoformans serotype A is confined to few microsatellite genotypes","volume":"7","author":"Pan","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"2024062717013902000_bib107","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.diagmicrobio.2011.07.007","article-title":"Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method","volume":"71","author":"Pfaller","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"2024062717013902000_bib55","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/myc.13041","article-title":"Genotypic diversity in clinical and environmental isolates of Cryptococcus neoformans from India using multilocus microsatellite and multilocus sequence typing","volume":"63","author":"Prakash","year":"2020","journal-title":"Mycoses"},{"issue":"1","key":"2024062717013902000_bib37","doi-asserted-by":"crossref","first-page":"e0007984","DOI":"10.1371\/journal.pntd.0007984","article-title":"Epidemiological characteristics of cryptococcal meningoencephalitis associated with Cryptococcus neoformans var. grubii from HIV-infected patients in Madagascar: A cross-sectional study","volume":"14","author":"Rakotoarivelo","year":"2020","journal-title":"PLoS NeglTrop Dis"},{"issue":"6","key":"2024062717013902000_bib59","doi-asserted-by":"crossref","first-page":"151336","DOI":"10.1016\/j.ijmm.2019.151336","article-title":"Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017","volume":"309","author":"Selb","year":"2019","journal-title":"Int J Med Microbiol"},{"issue":"12","key":"2024062717013902000_bib48","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.1128\/AAC.01299-15","article-title":"Increased antifungal drug resistance in clinical isolates of Cryptococcus neoformans in Uganda","volume":"59","author":"Smith","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"5-6","key":"2024062717013902000_bib49","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11046-012-9528-9","article-title":"Comparative analysis of the Vitek 2 antifungal susceptibility system and E-test with the CLSI M27-A3 broth microdilution method for susceptibility testing of indian clinical isolates of Cryptococcus neoformans","volume":"173","author":"Tewari","year":"2012","journal-title":"Mycopathologia"},{"issue":"4","key":"2024062717013902000_bib39","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/mmy\/myz082","article-title":"Cryptococcus neoformans infection in Human Immunodeficiency Virus (HIV)-infected and HIV-uninfected patients at an inner-city tertiary care hospital in the Bronx","volume":"58","author":"Yoon","year":"2020","journal-title":"Med Mycol"},{"issue":"6","key":"2024062717013902000_bib42","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/cid\/cis529","article-title":"Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and death","volume":"55","author":"Chen","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2024062717013902000_bib41","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cit341","article-title":"Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii","volume":"57","author":"Chen","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2024062717013902000_bib63","doi-asserted-by":"crossref","first-page":"e0004861","DOI":"10.1371\/journal.pntd.0004861","article-title":"MLST and whole-genome-based population analysis of Cryptococcus gattii VGIII links clinical, veterinary and environmental strains, and reveals divergent serotype specific sub-populations and distant ancestors","volume":"10","author":"Firacative","year":"2016","journal-title":"PLoS NeglTrop Dis"},{"issue":"12","key":"2024062717013902000_bib79","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/cid\/cir723","article-title":"Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen","volume":"53","author":"Harris","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2024062717013902000_bib64","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/mmy\/myy161","article-title":"Molecular types of Cryptococcus neoformans and Cryptococcus gattii in Western Australia and correlation with antifungal susceptibility","volume":"57","author":"Lee","year":"2019","journal-title":"Med Mycol"},{"issue":"2","key":"2024062717013902000_bib62","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.diagmicrobio.2012.02.018","article-title":"Epidemiologic cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibility","volume":"73","author":"Lockhart","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"9","key":"2024062717013902000_bib43","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/cid\/civ041","article-title":"Longitudinal clinical findings and outcome among patients with Cryptococcus gattii infection in British Columbia","volume":"60","author":"Phillips","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2024062717013902000_bib40","doi-asserted-by":"crossref","first-page":"e88875","DOI":"10.1371\/journal.pone.0088875","article-title":"Treatment and outcomes among patients with Cryptococcus gattii infections in the United States Pacific Northwest","volume":"9","author":"Smith","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"2024062717013902000_bib44","doi-asserted-by":"crossref","first-page":"e2338","DOI":"10.1093\/cid\/ciaa1544","article-title":"Antifungal susceptibility does not correlate with fungal clearance or survival in AIDS-associated cryptococcal meningitis","volume":"73","author":"O'Connor","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024062717013902000_bib65","first-page":"675213","article-title":"Global molecular epidemiology of Cryptococcus neoformansand Cryptococcus gattii: an atlas of the molecular types","volume":"2013","author":"Cogliati","year":"2013","journal-title":"Scientifica (Cairo)"},{"issue":"7","key":"2024062717013902000_bib72","first-page":"1122","article-title":"Long-term mortality and disability in cryptococcal meningitis: a systematic literature review","volume":"66","author":"Pasquier","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"14","key":"2024062717013902000_bib73","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1110404","article-title":"Combination antifungal therapy for cryptococcal meningitis","volume":"368","author":"Day","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"2024062717013902000_bib75","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/cid\/cix430","article-title":"Advanced Human Immunodeficiency Virus disease in Botswana following successful antiretroviral therapy rollout: incidence of and temporal trends in cryptococcal meningitis","volume":"65","author":"Tenforde","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"9","key":"2024062717013902000_bib76","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2217\/fvl.13.71","article-title":"Primary prophylaxis for cryptococcal meningitis and impact on mortality in HIV: a systematic review and meta-analysis","volume":"8","author":"Ssekitoleko","year":"2013","journal-title":"Future Virol"},{"issue":"4","key":"2024062717013902000_bib77","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/cid\/ciy567","article-title":"Impact of routine cryptococcal antigen screening and targeted preemptive fluconazole therapy in antiretroviral-naive Human Immunodeficiency Virus-infected adults with CD4 cell counts &lt;100\/\u03bcl: a systematic review and meta-analysis","volume":"68","author":"Temfack","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2024062717013902000_bib78","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/s12879-020-05126-z","article-title":"The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts &lt;\u2009200 cells\/\u03bcl: evidence based on a meta-analysis","volume":"20","author":"Li","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"7","key":"2024062717013902000_bib80","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/cid\/ciab268","article-title":"MSG07: an international cohort study comparing epidemiology and outcomes of patients with Cryptococcus neoformans or Cryptococcus gattii infections","volume":"73","author":"Baddley","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2024062717013902000_bib81","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/QAI.0000000000002095","article-title":"Mortality after cryptococcal infection in the modern antiretroviral therapy era","volume":"82","author":"Hevey","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"2024062717013902000_bib82","doi-asserted-by":"crossref","first-page":"e0007569","DOI":"10.1371\/journal.pntd.0007569","article-title":"Mortality by cryptococcosis in Brazil from 2000 to 2012: a descriptive epidemiological study","volume":"13","author":"Alves","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"2024062717013902000_bib83","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jmii.2010.08.011","article-title":"Comparisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection","volume":"44","author":"Lee","year":"2011","journal-title":"J Microbiol Immunol Infect"},{"issue":"7","key":"2024062717013902000_bib84","first-page":"1122","article-title":"Long-term mortality and disability in cryptococcal meningitis: a systematic literature review","volume":"66","author":"Pasquier","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"11","key":"2024062717013902000_bib85","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1093\/cid\/ciaa296","article-title":"A multicenter, longitudinal cohort study of cryptococcosis in Human Immunodeficiency Virus-negative people in the United States","volume":"71","author":"Pan","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"11","key":"2024062717013902000_bib86","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1710922","article-title":"Antifungal combinations for treatment of cryptococcal meningitis in Africa","volume":"378","author":"Molloy","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"2024062717013902000_bib87","doi-asserted-by":"crossref","first-page":"e25416","DOI":"10.1002\/jia2.25416","article-title":"Mortality from HIV-associated meningitis in sub-Saharan Africa: a systematic review and meta-analysis","volume":"23","author":"Tenforde","year":"2020","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"2024062717013902000_bib88","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.fbr.2020.10.003","article-title":"The one health problem of azole resistance in Aspergillus fumigatus: current insights and future research agenda","volume":"34","author":"Verweij","year":"2020","journal-title":"Fung Biol Rev"},{"issue":"9983","key":"2024062717013902000_bib89","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(15)60164-7","article-title":"Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial","volume":"385","author":"Mfinanga","year":"2015","journal-title":"Lancet"},{"key":"2024062717013902000_bib90","volume-title":"Guidelines for the Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-Infected Adults, Adolescents and Children: Supplement to the 2016 Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection","author":"WHO Guidelines Approved by the Guidelines Review Committee","year":"2018"},{"issue":"7","key":"2024062717013902000_bib91","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/cid\/ciaa016","article-title":"Cerebrospinal fluid early fungicidal activity as a surrogate endpoint for cryptococcal meningitis survival in clinical trials","volume":"71","author":"Pullen","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024062717013902000_bib92","article-title":"Innovative quantitative PCR assays for the assessment of HIV-associated cryptococcal meningoencephalitis in Sub-Saharan Africa","author":"Tshepiso","year":"2023"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/62\/6\/myae043\/58350510\/myae043.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/62\/6\/myae043\/58350510\/myae043.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T05:37:49Z","timestamp":1731821869000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myae043\/7700342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":106,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,27]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myae043","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6]]},"published":{"date-parts":[[2024,6]]},"article-number":"myae043"}}